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ABSTRACT 
The incorporation of nutritional screening and comprehensive assessments of oxidative stress is increasingly 
recognised as imperative in the development of standards for quality care in oncology. This study evaluated the 
levels of nitric oxide (NO), some essential trace metals (Zn, Cu, Fe, and Se), superoxide dismutase (SOD) activity 
and malondialdehyde (MDA) in twenty five (25) patients with acute leukaemia and 25 apparently healthy 
controls. The mean levels of plasma Zinc (Zn), Iron (Fe) and Selenium (Se) were not significantly elevated (p > 
0.05) in leukaemia patients compared with controls. Also, slightly lower level of plasma Cu was observed in 
leukaemia patients compared with the controls. However, nitric oxide was significantly increased (p < 0.05) in 
leukaemia patients compared with controls. The implication of the present finding is that intervention to 
increase antioxidant status in patients with Acute Lymphoblastic Leukaemia (ALL) should be considered.   
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INTRODUCTION 
Leukaemia, a haemopoietic cells’ neoplasm, is bone 
marrow malignancies often characterised by 
abnormal increase in white blood cells. Leukaemia 
constitutes the twelfth most common class of 
neoplastic disease, and the eleventh most common 
cause of cancer-related death. About 90% of all 
leukaemia are diagnosed in adults (Mathers et al., 
2001; LLS, 2009). 
 
Although, the exact cause of leukaemia is still 
unknown, scientists suspected that viral, genetic, 
environmental or immunological factors may be 
involved (Tanner et al., 2001). There are two main 
categories of leukaemia: acute and chronic. Chronic 
leukaemia is primarily the disease of adults, with 
the exception of chronic myelogenous leukaemia 
which sparingly occur in children. In acute 
leukaemia, about 80% of Acute Lymphoblastic 
Leukaemia (ALL) occurs in children and Acute 
Myeloblastic Leukaemia (AML) is far more common 
in adults. While acute leukaemia is acutely fatal if 
untreated, the chronic leukaemia is relentlessly 
insidious and may only be diagnosed in the early 
stage during routine medical check-up (Devi et al., 
2000). 
 
The incorporation of nutritional screening and 
comprehensive assessments is increasingly 
recognised as imperative in the development of 
standards for quality care in oncology (McMahon et 
al., 1998). Trace elements have been extensively 
studied over recent years to assess whether they 
have any modifying effects regarding the aetiology 
of cancer. Different researchers have tried to 
establish a relationship between trace elements and 
malignant diseases. Changes in blood levels of zinc 
and copper have been found in lymphoproliferative 
disorders as well as in breast, lung and 
gastrointestinal tumours (Oyama et al., 1994; Rosas 
et al., 1995; Jayadeep et al., 1997; Ferrigno et al., 
1999; Arinola and Charles-Davies, 2008). Several 
studies have implicated oxidative stress in the 
development of several chronic diseases including 
cancer (Mehmet et al., 2006). Zinc is an important 
element in the preservation of immune resistance
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and both Zn and Cu are required for numerous 
biochemical functions and for optimal activity of the 
immune system (Taysi et al., 2003). Copper (Cu) 
and Fe can catalyse the formation of the highly 
reactive hydroxyl radicals from H2O2 via the Haber-
Weiss reaction and decompose lipid peroxides to 
peroxyl and alkoxyl radicals, which favours the 
propagation of lipid oxidation (Zago and Oteiza, 
2001).  
 
Nitric Oxide (NO) is a free radical and 
multifunctional molecule that is produced in many 
mammalian cells (Tsumori et al., 2002). Previous 
studies showed that NO has cytotoxic effects on 
human cell lines from patients with leukaemia or 
lymphoma (Kwon et al., 1991; Jiang et al., 1992; 
Magrinat et al., 1992; Dugas et al., 1996; Filep et al., 
1996), thus, raising the possibility that a NO donor 
might serve as a chemotherapeutic agent for acute 
leukaemia. 
 
Therefore, this study evaluated the levels of NO, 
some essential trace metals (Zn, Cu, Fe, and Se), 
Superoxide dismutase (SOD) activity and 
malondialdehyde (MDA) in Nigerians with acute 
leukaemia so as to define their roles in improving 
treatment or appropriate care in remission. 
 
MATERIALS AND METHODS 
Patients  
Twenty five (25) consecutive newly diagnosed 
patients with acute leukaemia (14 ALL and 11 
AML), with age range of 4 to 50 years were selected 
through constellation of clinical features, full blood 
count and bone marrow studies. The patients were 
attending clinic in the Department of Haematology, 
University College Hospital, Ibadan, Nigeria 
between March, 2008 and November, 2010. Twenty 
five age-matched healthy subjects were taken as 




Five millilitres (5 ml) of venous blood was collected 
from each subject into heparinised bottles to obtain 
plasma after centrifugation for 5 minutes at 4000 x 
g. The plasma obtained was stored at -200C until 
analysed. For trace element assays, all the materials 
(glass and plastic) used were thoroughly cleaned 
with hot solution of nitric acid (20%, v/v) for 48 
hours and rinsed five times with deionised water. 
Trace metals (Cu, Zn, Se, and Fe) levels were 
determined using Beck 200 Atomic Absorption 
Spectrophotometer (AAS) as described by Arinola 
and Charles-Davies, 2008). The method is based on 
the principle that atoms of the elements vaporised 
when aspirated into the AAS and absorb light of the 
same wavelength as that emitted by the element 
when in the excited state. The level of NO was 
determined with Griess reagents using 
spectrophotometric method (Laudanska et al., 
1970). Superoxide Dismutase (SOD) and 
malondialdehyde (MDA) levels were determined 
using Enzyme Linked Immunosorbent assay 
(ELISA) kits (Cell Biolabs, Inc., USA) following the 
manufacturer’s procedure.  
 
Statistical Analysis 
Statistical analysis was performed with Statistical 
Package for the Social Sciences for Windows (SPSS, 
version 15.0). Results were expressed as mean ± SD 
and student t-test was used to compare the means. 




The mean levels of plasma Zn, Fe and Se were 
slightly elevated in leukaemia patients compared 
with controls. Also slightly lower level of plasma Cu 
was observed in leukaemia patients compared with 
the control. However, NO was significantly 
increased in leukaemia patients compared with 
controls (p < 0.05). 
 












6.63 ± 1.93 
116.00 ± 26.02 
132.78 ± 33.00  
59.86 ± 9.01 
4.99 ± 3.68 
109.28 ± 39.51 
33.12 ± 19.61 
 5.91 ± 2.08 
 119.58 ± 34.72 
 122.84 ± 35.73 
 56.72 ± 14.45 
 4.26 ± 2.74 
 97.44 ± 33.64 
















*P is significant at p < 0.05 value (2-tailed) 




Acute leukaemia (myeloblastic and lymphoblastic) 
is characterised by the rapid growth of abnormal 
clone of haemopoietic precursor cell within the 
bone marrow leading to undue accumulation in the 
bone marrow. This interferes with the normal 
process of haemopoiesis. The blasts also spill over 
into circulation and infiltrate various tissues and 
organs (LLS, 2009).  The biological role of trace 
elements, especially serum copper and zinc, in 
different physiological and pathological conditions 
has been extensively investigated (Rosas et al., 
1995; Arinola and Charles-Davies 2008).  
 
Changes in copper and zinc concentrations have 
been found in lymphoproliferative disorders and 
also in ovarian, breast, lung and gastrointestinal 
tumours (Rosas et al., 1995; Arinola and Charles-
Davies 2008). Statistically, no significant differences 
were observed in the mean plasma levels of all the 
parameters investigated in this study except NO in 
acute Leukaemia patients compared with controls. 
This observation corroborates earlier reports in 
acute leukaemia and other forms of malignancy 
(Magalova et al., 1999; Sgarbieri et al., 2006) but 
contradicts observation of Mehemet et al. (2006) in 
chronic lymphocytic leukaemia patients.  
 
In the present study, levels of plasma Zn, Fe, Se, SOD 
and MDA were slightly elevated in acute leukaemia 
patients compared with controls whereas slightly 
lower level of plasma Cu was observed in leukaemia 
patients. The observed slightly raised level of Fe 
could be as a result of slightly elevated plasma level 
of superoxide activity which releases Fe2+ from 
ferritin thus, catalysing formation of hydroxyl 
radicals from H2O2 via the Haber-Weiss reaction. 
Also, this decomposes lipid peroxides to peroxyl 
and alkoxyl radicals that favour propagation of lipid 
oxidation (Murray et al., 2003). Superoxide 
dismutase activity and plasma MDA level were 
elevated in acute leukaemia patients compared 
with controls although the difference was not 
statistically significant. This shows that there is 
slightly increased lipid peroxidation in leukaemia 
patients possibly, as a result of oxidative stress due 
to free radical production.  
 
Previous studies concluded that paediatric patients 
with ALL have higher oxidative stress but lower 
levels of antioxidants than healthy counterparts 
(Abou-Seif, 2000; Singh et al., 2001; Phanphen et al., 
2008). The implication of the present study is that 
intervention to increase antioxidant status in 
patients with ALL should be considered. Davi et al. 
(2000) reported that there were no significant 
differences in plasma malondialdehyde levels, red 
cell copper zinc superoxide dismutase (Cu-Zn SOD) 
and glutathione peroxidase (GSH-PX) activities in 
different types of leukaemia, suggesting that the 
changes are not specific to the type of leukaemia. A 
study showed that, the combination of phenolic 
antioxidant compounds (such as curcumin, 
carnosol, or quercetin) in conjunction with NOS 
inhibitors may be particularly valuable as a novel 
strategy for treating acute leukaemia (Kellner and 
Zunino, 2004).  
 
Another study demonstrated that sodium 
nitroprusside (SNP), a NO donor, had cytotoxic 
effects on cells of some patients with Malignant 
Lymphoma (ML), Acute Myeloblastic Leukaemia 
(AML) or Chronic Myelomonocytic Leukaemia 
(CMMoL), but not with multiple myeloma (Tsumori 
et al., 2002). Also, elevated production of NO has 
been observed in B-cell chronic lymphocytic 
leukaemia, and appears to play a survival role in 
these types of cells (Zhao et al., 1998; Kolb, 2000). 
Therefore, significantly raised level of NO observed 
in the present study suggests that elevated nitric 
oxide might be a potential chemotherapeutic target 
for the treatment of acute leukaemia. In general, the 
results of this study suggest that oxidative stress is 
a feature of acute leukaemia and NO may be 




Abou-Seif MA, Rabia A and Nasr M (2000). 
Antioxidant Status, Erythrocyte Membrane Lipid 
Peroxidation and Osmotic Fragility in Malignant 
Lymphoma Patients. Clin Chem lab Med. 38: 737-
742 
 
Arinola OO and Charles-Davies MA (2008). The 
Plasma Levels of Trace Elements in Nigerian Males 
with Different PSA Values. Malaysian J Med Sci. 15 
(2): 33-36 
 
Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN 
and Reddy PP. (2000). Free Radicals Antioxidant 
Enzymes and Lipid Peroxidation in Different Types 
of Leukaemia. Clin Chem Acta. 293(1-2): 53-62 
 
Dugas N, Mossalayi, MD, Calenda A, Léotard A, 
Bécherel P, Mentz F, Ouaaz F, Arock M, Debré P, 
Donald J and Dugas B (1996). Role of Nitric Oxide in 
the Anti-tumoral Effect of Retinoic acid and 1, 2, 5-
Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 135 
 
 
dihydroxyvitamine D3 on Human Promyelocytic 
Leukemic Cells. Blood. 88:3528–3534 
 
Ferrigno D, Buccheri G and Camilla T (1999). Serum 
Copper and Zinc Content in Non-small Cell Lung 
Cancer: Abnormalities and Clinical Correlates. 
Monaldi Arch Chest Dis. 54(3):204-208 
 
Filep JG, Baron C, Lachances S, Perreault C and Chan 
JSD (1996). Involvement of Nitric Oxide in Target-
cell Lysis and DNA Fragmentation Induced by 
Murine Natural Killer Cells. Blood. 87: 5136–5143 
 
Jayadeep A, Raveendran Pillai K and Kannan S 
(1997). Serum Levels of Copper, Zinc, Iron and 
Ceruplasmin in Oral Leukoplakia and Squamous 
Cell Carcinoma. J Exp Clin Cancer Res.16 (3):295-
300 
 
Jiang H, Stewart CA, Fast DJ and Leu RW (1992). 
Tumor Target-derived Soluble Factor Synergies 
with IFN-Gamma and IL-2 to Activate Macrophages 
for Tumor Necrosis Factor and Nitric Oxide 
Production to Mediate Cytotoxicity of the Same 
Target. J Immunol. 149: 2137–2146 
 
Kellner C and Zunino SJ (2004). Nitric Oxide is 
Synthesized in Acute Leukaemia Cells after 
Exposure to Phenolic Antioxidants and Initially 
Protects against Mitochondrial Membrane 
Depolarization. Cancer Lett. 44 (215): 43–52 
 
Kolb JP (2000). Mechanisms Involved in the Pro- 
and Anti-apoptotic Role of NO in Human 
Leukaemia. Leukaemia. 14: 1685–1694 
 
Kwon NS, Stuehr DJ and Nathan CF (1991). 
Inhibition of Tumor Cell Ribonucleotide Reductase 
by Macrophage-derived Nitric Oxide. J Exp Med. 
174: 761–767 
 
Laudanska E, Gwozdz A, Brudel G and Rajchert J 
(1970). Evaluation of Griess Reagent and TTC Tests 
in Obstetrics. Ginekol Pol. 41:857-862 
 
Leukaemia and Lymphoma Society (2009). 




Magalova T, Bella V, Brtkova A, Beno I, Kudlackova 
M and Volkovova K (1999). Copper, Zinc and Super 
Oxide Dismutase in Precancerous Bening Diseases 
and Gastric, Colorectal and Breast Cancer. 
Neoplasma. 46(2):100-104 
 
Magrinat G, Mason SN, Shami PJ and Weinberg JB 
(1992). Nitric Oxide Modulation of Human 
Leukaemia Cell Differentiation and Gene 
Expression. Blood. 80: 1880–1884 
 
Mathers CD, Boschi-Pinto C, Lopez AD and Murray 
CJL (2001). Cancer Incidence, Mortality and 
Survival by Site for 14 Regions of the World. Global 
Programme on Evidence for Health Policy Discussion 
Paper No. 13: World Health Organization 
 
McMahon K, Decker G and Ottery FD (1998). 
Integrating Proactive Nutritional Assessment in 
Clinical Practices to Prevent Complications and 
Cost. Semin Oncol. 25:20-27 
 
Mehmet G, Hasan K, Ilhami G, Fuat E, Kerim C, 
Mustafa K and Adnan Y (2006). Oxidase Activity Of 
Ceruloplasmin And Some Acute Phase Reactant And 
Trace Element Concentrations In Serum Of Patients 
With Chronic Lymphocytic Leukaemia. SMJ. 52(1): 
24-27 
 
Oyama T, Matsuno K, Kawamoto T, Mitsudomi T, 
Shirakusa T and Kodama Y (1994). Efficiency of 
Serum Copper/Zinc Ratio for Differential Diagnosis 
of Patients With and Without Lung cancer. Biol 
Trace Elem Res. 42 (2):115-127 
 
Phanphen P, Nalinee C, Samart P, Rachaneekorn WK 
and Umaporn S (2008). Antioxidant Status and 
Lipid Peroxidation in Pediatric Patients with Acute 
Lymphoblastic Leukaemia.  FASEB J.22:890-899 
 
Rosas R, Poo JL, Montemayor A, Isoard F, Majluf A 
and Labardini J (1995). Utilidad De la Relación 
Cobre/zinc en Pacientes Con Linfoma o Leucemias 
Aguda o Crónica. [Utility of the Copper/Zinc Ratio in 
Patients with Lymphoma or Acute or Chronic 
Leukaemias]. Rev Invest Clin. 47(6):447-452 
 
Sgarbieri UR, Fisberg M, Tone LG and Latorre MD 
(2006). Nutritional Assessment and Serum Zinc and 
Copper Concentration among Children with Acute 
Lymphocytic Leukaemia: A Longitudinal Study. Sao 
Paulo Med J. 124(6):316-320 
 
Singh V, Ghalaut PS, Kharb S and Singh GP (2001). 
Plasma Concentrations of Lipid Peroxidation 
Products in Children with Acute Leukaemia. Indian J 
Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 136 
 
 
Med Sci. 55(4): 215-217 
 
Tanner SM, Austin JL, Gustavo L and Baal C (2001). 
The Human Member of a Novel Mammalian 
Neuroectoderm Gene Lineage is Implicated in 
Hematopoiesis and Acute Leukaemia. Proc Natl 
Acad Sci. 98: 13901-13906 
 
Taysi S, Akcay F, Uslu C, Dogru Y and Gulcin I 
(2003). Trace Elements and Some Extracellular 
Antioxidant Proteins Levels in Serum of Patients 
with Laryngeal Cancer. Biol Trace Elem Res. 91(1): 
11-8 
 
Tsumori M, Tanaka J, Koshimura K, Kawaguchi M, 
Murakami Y and Kato Y (2002). Cytotoxic Effect of 
Nitric Oxide on Human Haematological Malignant 
Cells. Acta Biochimica Polonica. 49 (1) 139–144 
 
Zago MP and Oteiza PI (2001). The Antioxidant 
Properties of Zinc: Interactions with Iron and 
Antioxidants. Free Rad Biol Med. 31(2): 266-74 
 
Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, 
Sigaux F and Kolb JP (1998). B-cell Chronic 
Lymphocytic Leukaemia Cells Express a Functional 
Inducible Nitiric Oxide Synthase Displaying 
































Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 137 
